These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 7548753
41. Oxidation of 1-amino-4-phenyl-1,2,3,6-tetrahydropyridine, a 1-amino analog of MPTP, by type A and B monoamine oxidase. Umeda M, Aoyama S, Kaiya T, Kohda K, Maruyama W, Naoi M. J Neural Transm (Vienna); 1998; 105(10-12):1253-64. PubMed ID: 9928894 [Abstract] [Full Text] [Related]
42. Interactions of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidases. Singer TP, Salach JI, Castagnoli N, Trevor A. Biochem J; 1986 May 01; 235(3):785-9. PubMed ID: 3489461 [Abstract] [Full Text] [Related]
43. Monoamine oxidase and the bioactivation of MPTP and related neurotoxins: relevance to DATATOP. Heikkila RE, Terleckyj I, Sieber BA. J Neural Transm Suppl; 1990 May 01; 32():217-27. PubMed ID: 2128498 [Abstract] [Full Text] [Related]
44. Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2'Me-MPTP. Kindt MV, Youngster SK, Sonsalla PK, Duvoisin RC, Heikkila RE. Eur J Pharmacol; 1988 Feb 09; 146(2-3):313-8. PubMed ID: 3131149 [Abstract] [Full Text] [Related]
45. Studies on the mechanism of MPTP oxidation by human liver monoamine oxidase B. Gessner W, Brossi A, Bembenek ME, Fritz RR, Abell CW. FEBS Lett; 1986 Apr 07; 199(1):100-2. PubMed ID: 3485542 [Abstract] [Full Text] [Related]
47. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain. Fuller RW, Robertson DW, Hemrick-Luecke SK. J Pharmacol Exp Ther; 1987 Feb 07; 240(2):415-20. PubMed ID: 3100775 [Abstract] [Full Text] [Related]
49. Synthesis and in vitro biological evaluation of fluoro-substituted-4-phenyl-1,2,3,6-tetrahydropyridines as monoamine oxidase B substrates. Beeler AB, Gadepalli RS, Steyn S, Castagnoli N, Rimoldi JM. Bioorg Med Chem; 2003 Nov 17; 11(23):5229-34. PubMed ID: 14604687 [Abstract] [Full Text] [Related]
51. Studies on the cytochrome P-450 catalyzed ring alpha-carbon oxidation of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Ottoboni S, Carlson TJ, Trager WF, Castagnoli K, Castagnoli N. Chem Res Toxicol; 1990 Nov 17; 3(5):423-7. PubMed ID: 2133093 [Abstract] [Full Text] [Related]
54. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites. Itzhak Y, Mash D, Zhang SH, Stein I. Mol Pharmacol; 1991 Mar 17; 39(3):385-93. PubMed ID: 1848660 [Abstract] [Full Text] [Related]
55. Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Castagnoli N, Chiba K, Trevor AJ. Life Sci; 1985 Jan 21; 36(3):225-30. PubMed ID: 3871243 [Abstract] [Full Text] [Related]
56. Metabolic studies on the nigrostriatal toxin MPTP and its MAO B generated dihydropyridinium metabolite MPDP+. Wu E, Shinka T, Caldera-Munoz P, Yoshizumi H, Trevor A, Castagnoli N. Chem Res Toxicol; 1988 Jan 21; 1(3):186-94. PubMed ID: 2979730 [Abstract] [Full Text] [Related]
59. A novel and selective monoamine oxidase B substrate. Rimoldi JM, Puppali SG, Isin E, Bissel P, Khalil A, Castagnoli N. Bioorg Med Chem; 2005 Oct 15; 13(20):5808-13. PubMed ID: 15993094 [Abstract] [Full Text] [Related]
60. Age-dependent effects of the 2'-methyl analog of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: prevention by inhibitors of monoamine oxidase B. Finnegan KT, Irwin I, Delanney LE, Langston JW. J Pharmacol Exp Ther; 1995 May 15; 273(2):716-20. PubMed ID: 7752075 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]